Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

semiQ2 Semiquantification based on ionization efficiency for human exposure leveraging ion mobility separation

Coordinator
Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Runs
16 September 2026 to 15 September 2028
Status
Running
EU funding
€210k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101284472

What the project is doing

In the project's own words, from its summary on CORDIS.

Exposomics has revolutionized our understanding of how environmental factors influence diseases such as asthma, cancer, Alzheimer’s, Parkinson’s, and undiagnosed conditions. Exposure characterization enables epidemiologists to link biological pathways to disease outcomes. Contaminants of Emerging Concern (CECs), including industrial chemicals, pharmaceuticals, and persistent “forever chemicals,” are now commonly found in the environment and human samples.

Detecting these compounds in biological matrices is not enough; quantification is essential to ensure their levels stay below thresholds associated with adverse health effects. Advances in liquid chromatography high-resolution mass spectrometry (LC-HRMS) have enhanced the targeted detection and quantification of CECs. However, this method depends on access to reference standards, which is impractical for non-target screening, where standards may be unavailable.

Quantitative non-target screening (q-NTS) provides an alternative by offering concentration data for unknown compounds, enabling data interpretation beyond simple relative peak areas. We propose a new q-NTS approach optimized for human samples, using ion mobility separation to resolve co-elution issues. Employing LC-trapped ion mobility separation-HRMS (LC-TIMS-HRMS) and covering a broad range of CECs, our goal is to develop an LC-mobility resolved ionization efficiency (IE) model for both negative and positive electrospray ionization.

These models will consider chemical structure, LC conditions (mobile phase and pH), adduct types, and signal areas from mobility versus intensity. TIMS is expected to reduce matrix complexity in biological samples, improving IE model accuracy and semiquantification. We will test the accuracy of these models using urine and blood samples from a prospective cohort of at least 60 participants (30 healthy and 30 patients).

Risk assessment and prioritization of the detected CECs will utilize the generated semiquantitative data.

Topics

Who is involved

OrganisationCityCountryRole
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI